MicroRNA-377 Inhibited Proliferation and Invasion of Human Glioblastoma Cells by Directly Targeting Specificity Protein 1.
Rui Zhang,Hui Luo,Shuai Wang,Wanghao Chen,Zhengxin Chen,Hong-Wei Wang,Yuanyuan Chen,Jingmin Yang,Xiaotian Zhang,Wenting Wu,Shu-Yu Zhang,Shuying Shen,Qingsheng Dong,Yaxuan Zhang,Tao Jiang,Daru Lu,Shiguang Zhao,Yongping You,Ning Liu,Huibo Wang
DOI: https://doi.org/10.1093/neuonc/nou111
2014-01-01
Neuro-Oncology
Abstract:Background. Increasing evidence has indicated that microRNAs (miRNAs) are strongly implicated in the initiation and progression of glioblastoma multiforme (GBM). Here, we identified a novel tumor suppressive miRNA, miR-377, and investigated its role and therapeutic effect for GBM.Methods. MiRNA global screening was performed on GBM patient samples and adjacent nontumor brain tissues. The expression of miR-377 was detected by real-time reverse-transcription PCR. The effects of miR-377 on GBM cell proliferation, cell cycle progression, invasion, and orthotopic tumorigenicity were investigated The therapeutic effect of miR-377 mimic was explored in a subcutaneous GBM model. Western blot and luciferase reporter assay were used to identify the direct and functional target of miR-377.Results. MiR-377 was markedly downregulated in human GBM tissues and cell lines. Overexpression of miR-377 dramatically inhibited cell growth both in culture and in orthotopic xenograft tumor models, blocked G1/S transition, and suppressed cell invasion in GBM cells. Importantly, introduction of miR-377 could strongly inhibit tumor growth in a subcutaneous GBM model. Subsequent investigation revealed that specificity protein 1 (Sp1) was a direct and functional target of miR-377 in GBM cells. Silencing of Sp1 recapitulated the antiproliferative and anti-invasive effects of miR-377, whereas restoring the Sp1 expression antagonized the tumor-suppressive function of miR-377. Finally, analysis of miR-377 and Sp1 levels in human GBM tissues revealed that miR-377 is inversely correlated with Sp1 expression.Conclusion. These findings reveal that miR-377/Sp1 signaling that may be required for GBM development and may consequently serve as a therapeutic target for the treatment of GBM.